发明名称 Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2
摘要 <p>The use of the long pentraxin PTX3 (PTX3) or a functional derivatives thereof or its domain for the preparation of medicament which inhibits the biological activity of the growth factor FGF-2, useful for the prevention and treatment of diseases brought about by an altered activation of said growth factor FGF-2 is described.</p>
申请公布号 SK287791(B6) 申请公布日期 2011.10.04
申请号 SK20030000562 申请日期 2001.11.08
申请人 SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. 发明人 MANTOVANI ALBERTO;BOTAZZI BARBARA;PRESTA MARCO;RUSNATI MARCO
分类号 A61K38/17;A61K45/00;A61K35/12;A61K35/76;A61K38/00;A61K39/39;A61K45/06;A61K48/00;A61P3/10;A61P9/00;A61P9/08;A61P9/10;A61P17/06;A61P19/00;A61P19/02;A61P25/00;A61P27/02;A61P29/00;A61P35/00;A61P35/04;A61P43/00;C07K14/47 主分类号 A61K38/17
代理机构 代理人
主权项
地址